Beliver Insights

Welcome to Beliver News, your go-to source for the latest updates on our mission to transform cancer treatment. At Beliver, we are committed to reinventing treatment selection, empowering oncologists with rational and enlightened therapeutic decisions. Here, you’ll find breakthroughs in precision oncology, company milestones, expert insights, and more. Stay informed and join us as we shape the future of personalized cancer care.

EASL Liver Cancer Summit 2025

For BeLiver, this week was marked by our participation in the EASL hashtag#LiverCancerSummit 2025. A huge thank you to the organizers Julien Calderaro, Fabio Piscaglia, and Rocio IR Marcia for this event, which allowed us to exchange with experts and discover the latest advances in liver cancer care.

It was also an opportunity to present to the scientific community the latest research 🔬conducted by our CSO, Frederic Saltel, at BRIC-BoRdeaux Institute of onCology, as well as by our CTO, Anne-Aurélie Raymond thanks to the OncoProt platform, in partnership with CHU de Bordeaux. 🏥

This conference was a fantastic opportunity to expand our network 🌍, initiate new collaborations, and explore emerging trends in oncology.

BeLiver is more motivated than ever to accelerate innovation in the service of patients 🚀

Paris Saclay Cancer Cluster (PSCC)

On this World Cancer Day, BeLiver wishes to reaffirm its commitment to all those fighting against this disease. We continue to build a strong network of scientists and clinicians to provide cancer patients with a powerful tool that physicians can deeply rely on to deliver the most accurate treatment.

This day takes special meaning as we participate in the Paris Saclay Cancer Cluster (PSCC) Innovation Forum 2025. A huge thank you to the organizers and speakers for the quality of the discussions and presentations. It’s inspiring to see so many players mobilized to advance cancer care.

Innovation and collaboration are essential forces to progress. Let’s continue to innovate and fight together.

BioFIT Event

This week, our CEO, Madeleine Moscatelli, PhD, had the opportunity to pitch BeLiver’s vision during the BioFIT Event. It was an incredible chance for us to present our project and gather valuable feedback and insights.

We are deeply grateful to the organizers for creating such a dynamic space for innovation and collaboration.

A special thanks to Kevin Carvalho, Guillaume Picard, Laura Bergeon, Jean-Luc Chagnaud, and Liêm HUYNH VAN for their support and guidance over these two inspiring days.

© ALL RIGHTS RESERVED Legal informationCookie policy (EU)Privacy statement (EU)